AbbVie’s Prognosis: The February Dip Looks Like a Buy Signal AbbVie is on track to grow, drive cash flow, and pay a healthy dividend for the long term: institutions and analysts are accumulating this stock. MarketBeat · Feb 5
3 High-Risk Stocks That Soared in 2025 But Can Still Fly Higher High-risk stocks may fall out of favor in 2026, but select names still offer upside; here are three stocks that soared in 2025 and could keep climbing MarketBeat · Feb 5
2 REITs That Look Attractive in a Stable Rate Environment REITs don’t need aggressive rate cuts—just predictability. Simon Property Group and Healthpeak show why stable rates could support REITs in 2026 MarketBeat · Feb 4
52-Week Extremes: 4 Stocks You’ll Want in Your Portfolio Among Tuesday’s 509 new 52-week highs and 545 new 52-week lows on the NYSE and Nasdaq, four companies stand out as stocks you’ll want in your portfolio in 2026 and beyond. Barchart · Feb 4
The Atomic Pivot: AI’s $50 Billion Power Move Massive capital flows from tech giants are transforming the nuclear energy sector into the critical backbone of the modern artificial intelligence economy. MarketBeat · Feb 3
Gold, Copper, and Missiles: 3 Big Dividend Raises After a Breakout Year Big name stocks in the defense and mining industries are adding fuel to their dividends. See where their yields stand, and what may be in store going forward. MarketBeat · Feb 2
3 Stocks Trump Could Back Next as USA Rare Earths Revives the Federal Catalyst Trade Stocks to watch for a Trump White House stake include GlobalFoundries, Oklo and Energy Fuels, with USA Rare Earths and MP Materials as rare earth context. MarketBeat · Feb 2
Top 5 MarketRank™ Stocks Backed by Analysts and Big Institutions In a choppy tape, these five stocks spanning various sectors might offer a potential blueprint for building a resilient, high-conviction portfolio. MarketBeat · Feb 2
Defense Behemoths: Winners and Loser During Q4 Earnings Cycle Droves of U.S. defense giants reported earnings in late January. See which names in this red-hot industry impressed and disappointed during the quarter. MarketBeat · Feb 2
AstraZeneca shares launch on New York Stock Exchange The UK based-pharmaceutical giant is transitioning to the market by delisting American Depositary Shares from the Nasdaq index. Evening Standard · Feb 2
3 Emerging Market Stocks Leveraging South America’s Momentum Emerging markets have been outperforming the U.S. stock market as commodity strength and a weaker dollar drive capital flows. MarketBeat · Jan 31
MarketBeat Week in Review – 01/26 - 01/30 Despite another volatile week, the overall outlook for stocks continues to look favorable with each of the major averages up more than 1% in January MarketBeat · Jan 31
Physical AI: The Next Industrial Revolution Is Finally Here Investors are shifting focus from digital software to physical AI as labor shortages drive urgent demand for industrial automation and robotics. MarketBeat · Jan 30
After +50% Return in 2025, GM Gets Off to a Strong Start in 2026 General Motors just saw another big up-move after the company's latest earnings report, showing resiliency amid a soft auto market. MarketBeat · Jan 29
MarketBeat · Jan 29 Capital One Stock Weak After Earnings, Brex Deal in Focus Capital One stock slid after an earnings miss and the Brex acquisition announcement, which could be setting up a buy-the-dip opportunity
MarketBeat · Jan 29 Digging Into Demand: Copper’s Scarcity Premium Is Rising Copper prices are decoupling from traditional economic cycles as the massive power needs of artificial intelligence create a historic supply deficit.
MarketBeat · Jan 27 Space Stock Boom: Why Retail and Wall Street Are Aligning Retail investors and major Wall Street banks are uniting behind the orbital economy as space technology matures into a viable industrial asset class.
MarketBeat · Jan 26 Did BlackRock Build A New Floor for Archer's Stock Price? The world's largest asset manager has increased its stake in Archer Aviation, validating the company's financial strategy and its path to commercialization.
MarketBeat · Jan 26 3 Dividend-Backed Consumer Staples to Reinforce Your Portfolio The consumer staples sector is a popular hideout for investors during volatile markets. Consider these three stocks to strengthen your portfolio.
MarketBeat · Jan 26 5 Alternative Energy Stocks Riding the AI Power Crunch AI-driven electricity demand is fueling a power crunch, pushing alternative energy stocks into one of the market’s strongest momentum themes.
MarketBeat · Jan 25 Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors Healthcare stocks rebounded in 2025. These three healthcare growth stocks offer exposure to innovation beyond traditional biotech risk
MarketBeat · Jan 24 What’s the Best Way to Buy Gold in 2026? Gold prices are near record highs in 2026; investors can choose between gold ETFs and mining stocks based on risk tolerance, liquidity, and return potential
TechRadar · Jan 23 Is this the future of trading? NYSE reportedly building a venue for 24/7 tokenized stock and EDF settling NYSE plans a blockchain-based 24/7 trading platform for tokenized stocks and ETFs with instant settlement and stablecoin support.
MarketBeat · Jan 22 Lemonade’s Tesla Deal Could Rewrite How Auto Insurance Is Priced Lemonade shares rose to a new yearly high following a strategic collaboration with Tesla to insure autonomous driving alongside improving financial metrics.
MarketBeat · Jan 21 ICE vs Coinbase: The Race for Dominance in a 24/7 Market Intercontinental Exchange and Coinbase are aggressively building the infrastructure required to dominate the emerging era of continuous global asset trading.